BUSINESS

Dr. Reddy’s Laboratories (RDY) Announces Rollout of Injectable Semaglutide Under Brand Name Obeda®

Apr 24, 2026 - 20:00
Dr. Reddy’s Laboratories (RDY) Announces Rollout of Injectable Semaglutide Under Brand Name Obeda®
Read More

Tags:

Previous Article

Yatra Online (YTRA) Announces Results for Q3 2026, and Overall Gross Bookings Ro...

Next Article

Wipro (WIT) Expects a Weak Q1 2027, Notes Reuters

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BofA Flags Investor Caution on The Goldman Sachs Group, Inc. (GS) Despite Solid Quarterly Performance

BofA Flags Investor Caution on The Goldman Sachs Group,...

Apr 24, 2026

Intel Surpasses 2000 Dot-Com Boom High, Hits New Record

Intel Surpasses 2000 Dot-Com Boom High, Hits New Record

Apr 24, 2026

Live Oak (LOB) Q3 2025 Earnings Transcript

Live Oak (LOB) Q3 2025 Earnings Transcript

Apr 22, 2026